Juan Hernandez-Prera

7PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPopular and genre literatureCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jun 28, 2023
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma.

Ritu Chaudhary, Robbert J C Slebos, Leenil C Noel

|Mar 21, 2022
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: The Neck and Lymph Nodes, Metastasis, and Melanocytic Tumors.

Juan C Hernandez-Prera

|Aug 27, 2021
Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland.

Miquel Quer, Juan C Hernandez-Prera, Carl E Silver

|Aug 19, 2021
Evaluation of programmed death ligand 1 immunohistochemistry in cytology specimens of head and neck squamous cell carcinoma.

Amin Heidarian, Bruce M Wenig, Juan C Hernandez-Prera

|Aug 19, 2021
Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature.

Juan C Hernandez-Prera, Daryoush Saeed-Vafa, Amin Heidarian

Pageof 2

Frequent Collaborators

2 joint publications

Jose A Guevara-Patino

2 joint publications

AikChoon Tan

2 joint publications

Maria I Poole

2 joint publications

Christine H Chung